Future Assay Development

The primary focus is to improve health by delivering rapid and accurate results at the point of care.

Research & Development is at the heart of our dedication to provide high quality diagnostic tools to aid clinical decision making. We are continually expanding our product portfolio in key areas of healthare, including primary care, emergency and urgent care, infection prevention and control and global health.

Q-POC machine

Next Steps for QMDx

  • Respiratory Panel
  • SARS (SARS-CoV-2)
Launched
Close up of hands in blue medical gloves interacting with a Q-Poc Machine
  • Tuberculosis (TB) (Latent and Drug Resistant)
  • HPV (Strategic Partners)
Launching Soon
Close up of hands holding a cassette of a q-poc machine
  • Additional Multiplex functionality and extended assay portfolio.
In Development
Q-Poc Machine
  • Sexually Transmitted Infection (STI) + Drug Resistance (DR)
  • Adult (in-patient) Respiratory Panel
  • Paediatric (in-patient) Respiratory Panel
  • Sepsis
In Development
Close up of hands analysing a sample with the cassette of a q-poc machine
  • Urinary Tract Infection (UTI)
  • Hepatitis
  • Gastrointestinal (GI)
  • Healthcare Associated Infections (HCAI)
  • Meningitis/Encephalitis
Future Development
Q-Poc Machine

Passionate about point-of-need multiplex diagnostics for:

Primary care and public health

  • Respiratory
  • STI/STI + (DR)
  • HPV
  • GI

Emergency and urgent care

  • Respiratory
  • UTI
  • Meningitis and encephalitis
  • HCAI
  • GI
  • Sepsis

Global health

  • TB
  • STI/STI + (DR)
  • HPV
  • GI

Infection prevention and control

  • HCAI
  • GI